Medicine
Ceftriaxone 2 g powder for injection
Ceftriaxone 2 g powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Ceftriaxone
- Brand
- Sold under the generic name
- Strength
- 2 g
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials, 25 vials, 1 vial and 9 more
- Manufacturers
- HospiraProficient RxWG Critical CareApotexCivicaHikma PharmaceuticalsQilu PharmaceuticalSagent PharmaceuticalsSandoz
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DD04 Ceftriaxone
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2005
- Identifiers
- RxCUI 1665005, 1665021, 1665046 +1DailyMed set ID 5cf93bc5-9e4c-4734-bc02-c7d0ac071022, 8351aa37-552d-471d-b293-c564dcb6ec29, 4cdf0743-c62b-4969-b9c9-4c6400644f6c +9NDC 25021-107, 0143-9856, 67184-1008 +7Application ANDA065329, ANDA065342, ANDA203702 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0409-7335-03 | Hospira | 9 May 2005 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0409-7335-20 | Hospira | 19 March 2018 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-702-25 | WG Critical Care | 24 July 2008 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-702-95 | WG Critical Care | 5 January 2023 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 60505-6149-4 | Apotex | 30 June 2017 |
| 25 vial in 1 box / 1 injection, powder, for solution in 1 vial | 0143-9856-25 | Hikma Pharmaceuticals | 10 January 2008 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 67184-1008-1 | Qilu Pharmaceutical | 29 June 2016 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 25021-107-20 | Sagent Pharmaceuticals | 5 November 2009 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0781-3209-95 | Sandoz | 9 May 2005 |
| 1 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 71205-593-01 | Proficient Rx | 23 July 2021 |
| 1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 71205-710-01 | Proficient Rx | 31 October 2022 |
| 25 vial in 1 box / 1 injection, powder, for solution in 1 vial | 72572-062-25 | Civica | 1 March 2020 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0409-7336-04 | — | 20 July 2005 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 December 1984 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ceftriaxone 2 g powder for injection.
Other strengths and forms of Ceftriaxone
Clinical summary
Ceftriaxone is a cephalosporin antibacterial indicated for the treatment of infections when caused by susceptible bacteria, among other approved uses. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Ceftriaxone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CeftriaxoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CEFTRIAXONE AND DEXTROSE prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Ceftriaxone 2 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.